Geode Capital Management, LLC Age X Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.67 - $0.85 $28,964 - $36,745	43,230 Added 44.22%	140,994 $95,000
Q1 2023 May 15, 2023	SELL	$0.56 - $0.8 $1,034 - $1,477	-1,847 Reduced 1.85%	97,764 $64,000
Q4 2022 Feb 13, 2023	SELL	$0.54 - $0.68 $136 - $171	-252 Reduced 0.25%	99,611 $54,000
Q2 2022 Aug 12, 2022	BUY	$0.57 - $1.0 $835 - $1,465	1,465 Added 1.49%	99,863 $57,000
Q2 2020 Aug 13, 2020	SELL	$0.68 - $1.13 $72,423 - $120,350	-106,505 Reduced 51.98%	98,398 $93,000
Q1 2020 May 14, 2020	BUY	$0.78 - $1.95 $4,252 - $10,631	5,452 Added 2.73%	204,903 $190,000
Q4 2019 Feb 13, 2020	BUY	$1.25 - $1.82 $191 - $278	153 Added 0.08%	199,451 $363,000
Q3 2019 Nov 12, 2019	BUY	$1.96 - $3.38 $11,277 - $19,448	5,754 Added 2.97%	199,298 $390,000
Q2 2019 Aug 14, 2019	BUY	$2.58 - $4.92 $169,911 - $324,016	65,857 Added 51.58%	193,544 $710,000
Q1 2019 May 14, 2019	BUY	$3.0 - $4.85 $15,510 - $25,074	5,170 Added 4.22%	127,687 $517,000
Q4 2018 Feb 13, 2019	BUY	$2.49 - $5.5 $305,067 - $673,843	122,517 New	122,517 $366,000

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.